With profitability forecast in 2025 and bullish guidance to boot, IMO would be absolutely mad to be selling this stock before profitability. Looking back at medical devices that have simplicity and applicability at their core, that change the standard of care and sweep the globe, they have made an absolute fortune commercially. Laryngeal Mask Airway (LMA) and penthrane whistle (the green whistle for pain relief) are two examples that have changed medical care and been huge commercial success stories. Everything points towards ReCell doing the same by vastly reducing the need for skin grafting pain and disfigurement the world over. IMO you'd be nuts to see until at least profitability, when the big fish will start to bite.
Don't consider selling before profitability
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.62 |
Change
-0.150(5.42%) |
Mkt cap ! $157.7M | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.66 | $2.58 | $1.612M | 614.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 13249 | $2.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.66 | 3448 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.62 |
Change
-0.150 ( 6.19 %) |
||||
| Open | High | Low | Volume | ||
| $2.61 | $2.65 | $2.61 | 10832 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| AVH (ASX) Chart |